课题基金 / 基金详情

Investigating the impact of drug policy reform on HIV-related risk behaviours and access to methadone maintenance treatment among injection drug users in Mexico

Investigating the impact of drug policy reform on HIV-related risk behaviours and access to methadone maintenance treatment among injection drug users in Mexico
调查毒品政策改革对墨西哥注射吸毒者艾滋病毒相关风险行为和获得美沙酮维持治疗的影响
批准号:
269683
负责人:
Werb Daniel M
金额:
$10.93万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-10-01 至 2015-10-01

项目摘要

项目成果

Werb Daniel M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The illicit drug trade in North America continues to proliferate, with the three countries of the continent - Canada, the United States, and Mexico - responding to the risk for HIV and other drug-related harms among injection drug users in a variety of wa
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Toronto Disparities, Overdose, and Treatment (T-DOT) Study: Investigating clinical outcomes among people who inject drugs during a period of rapid programmatic and policy change
  • 批准号:
    462231
  • 项目类别:
    Operating Grants
  • 资助金额:
    $113.69万
  • 财政年份:
    2022
  • 负责人:
    Werb Daniel M
  • 依托单位:
Rapidly assessing the impact of the COVID-19 pandemic and response on clinical and social outcomes, service utilization, and the unregulated drug supply experienced by people who use drugs in Toronto
  • 批准号:
    430301
  • 项目类别:
    Operating Grants
  • 资助金额:
    $15.06万
  • 财政年份:
    2020
  • 负责人:
    Werb Daniel M
  • 依托单位:
Preventing Injecting and Overdose by Disrupting Injection Drug Use Transitions: The PRIMER II Study
  • 批准号:
    434750
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.45万
  • 财政年份:
    2020
  • 负责人:
    Werb Daniel M
  • 依托单位:
国内基金
海外基金
基于病人旅程地图的HIV/AIDS患者双轨调适策略的混合性研究
基于潜变量增长混合模型的HIV/AIDS患者症状负担发展轨迹研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡亚丽
  • 依托单位:
基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
IL-33/NF-κB通路在臭氧暴露致HIV/AIDS患者免疫损伤中的调控机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: